Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination. Continue your routine care with us by scheduling an in-person appointment or Video Visit.
Department of Anesthesiology
Author Title Type [ Year(Desc)]
Filters: Author is Savarese, J J  [Clear All Filters]
1986
Savarese JJ.  1986.  Clinical relaxation: current controversy.. Can Anaesth Soc J. 33(3 Pt 2):S1-4.
deBros FM, Lai A, Scott R, deBros J, Batson AG, Goudsouzian N, Ali HH, Cosimi AB, Savarese JJ.  1986.  Pharmacokinetics and pharmacodynamics of atracurium during isoflurane anesthesia in normal and anephric patients.. Anesth Analg. 65(7):743-6.
Savarese JJ, Goldenheim PD, Thomas GB, Kaiko RF.  1986.  Steady-state pharmacokinetics of controlled release oral morphine sulphate in healthy subjects.. Clin Pharmacokinet. 11(6):505-10.
1987
Khojasteh A, Evans W, Reynolds RD, Thomas G, Savarese JJ.  1987.  Controlled-release oral morphine sulfate in the treatment of cancer pain with pharmacokinetic correlation.. J Clin Oncol. 5(6):956-61.
Meed SD, Kleinman PM, Kantor TG, Blum RH, Savarese JJ.  1987.  Management of cancer pain with oral controlled-release morphine sulfate.. J Clin Pharmacol. 27(2):155-61.
1988
Savarese JJ, Ali HH, Basta SJ, Embree PB, Scott RP, Sunder N, Weakly JN, Wastila WB, el-Sayad HA.  1988.  The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug.. Anesthesiology. 68(5):723-32.
Basta SJ, Savarese JJ, Ali HH, Embree PB, Schwartz AF, Rudd GD, Wastila WB.  1988.  Clinical pharmacology of doxacurium chloride. A new long-acting nondepolarizing muscle relaxant.. Anesthesiology. 69(4):478-86.
Ali HH, Savarese JJ, Embree PB, Basta SJ, Stout RG, Bottros LH, Weakly JN.  1988.  Clinical pharmacology of mivacurium chloride (BW B1090U) infusion: comparison with vecuronium and atracurium.. Br J Anaesth. 61(5):541-6.
Savarese JJ, Thomas GB, Homesley H, Hill CS.  1988.  Rescue factor: a design for evaluating long-acting analgesics.. Clin Pharmacol Ther. 43(4):376-80.
Goldhill DR, Embree PB, Ali HH, Savarese JJ.  1988.  Reversal of pancuronium. Neuromuscular and cardiovascular effects of a mixture of neostigmine and glycopyrronium.. Anaesthesia. 43(6):443-6.
1989
Savarese JJ, Ali HH, Basta SJ, Scott RP, Embree PB, Wastila WB, Abou-Donia MM, Gelb C.  1989.  The cardiovascular effects of mivacurium chloride (BW B1090U) in patients receiving nitrous oxide-opiate-barbiturate anesthesia.. Anesthesiology. 70(3):386-94.
Cundiff D, McCarthy K, Savarese JJ, Kaiko R, Thomas G, Grandy R, Goldenheim P.  1989.  Evaluation of a cancer pain model for the testing of long-acting analgesics. The effect of MS Contin in a double-blind, randomized crossover design.. Cancer. 63(11 Suppl):2355-9.
Goudsouzian NG, Alifimoff JK, Liu LM, Foster V, McNulty B, Savarese JJ.  1989.  Neuromuscular and cardiovascular effects of doxacurium in children anaesthetized with halothane.. Br J Anaesth. 62(3):263-8.
Goudsouzian NG, Alifimoff JK, Eberly C, Smeets R, Griswold J, Miler V, McNulty BF, Savarese JJ.  1989.  Neuromuscular and cardiovascular effects of mivacurium in children.. Anesthesiology. 70(2):237-42.
Brooks I, De Jager R, Blumenreich M, George E, Savarese JJ.  1989.  Principles of cancer pain management. Use of long-acting oral morphine.. J Fam Pract. 28(3):275-80.
1990
Dresner DL, Basta SJ, Ali HH, Schwartz AF, Embree PB, Wargin WA, Lai AA, Brady KA, Savarese JJ.  1990.  Pharmacokinetics and pharmacodynamics of doxacurium in young and elderly patients during isoflurane anesthesia.. Anesth Analg. 71(5):498-502.
1991
Fiamengo SA, Savarese JJ.  1991.  Use of muscle relaxants in intensive care units.. Crit Care Med. 19(12):1457-9.
1993
Kelly RE, Lien CA, Savarese JJ, Belmont MR, Hartman GS, Russo JR, Hollmann C.  1993.  Depression of neuromuscular function in a patient during desflurane anesthesia.. Anesth Analg. 76(4):868-71.
Lien CA, Gadalla F, Kudlak TT, Embree PB, Sharp GJ, Savarese JJ.  1993.  The effect of ondansetron on atracurium-induced neuromuscular blockade.. J Clin Anesth. 5(5):399-403.
1994
Goudsouzian NG, Savarese JJ.  1994.  Antagonizing residual neuromuscular block with neostigmine and atropine.. Br J Anaesth. 73(5):725.
Lien CA, Schmith VD, Embree PB, Belmont MR, Wargin WA, Savarese JJ.  1994.  The pharmacokinetics and pharmacodynamics of the stereoisomers of mivacurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia.. Anesthesiology. 80(6):1296-302.
1995
Savarese JJ, Lien CA, Belmont MR.  1995.  The accuracy of the 5%-25% (T1-T3) twitch recovery interval in predicting the speed of spontaneous recovery from mivacurium-induced neuromuscular blockade.. Anesth Analg. 80(1):209-10.
Lien CA, Belmont MR, Abalos A, Eppich L, Quessy S, Abou-Donia MM, Savarese JJ.  1995.  The cardiovascular effects and histamine-releasing properties of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia.. Anesthesiology. 82(5):1131-8.
Savarese JJ, Lien CA, Belmont MR, Rubin L.  1995.  The clinical and basic pharmacology of mivacurium: a short-acting nondepolarizing benzylisoquinolinium diester neuromuscular blocking drug.. Acta Anaesthesiol Scand Suppl. 106:18-22.
Belmont MR, Lien CA, Quessy S, Abou-Donia MM, Abalos A, Eppich L, Savarese JJ.  1995.  The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia.. Anesthesiology. 82(5):1139-45.